Stem-Cell Tourism Troubles Experts
 Posted on: Sunday, 13 July 2008, 06:00 CDT
 By Marie McCullough, The Philadelphia Inquirer 
 
 Jul. 13--In February, Marcela DeVivo took her baby son to the 
 Dominican Republic and paid $30,000 to have him injected with blood 
 stem cells from aborted fetuses. 
 
 Nathan, who turns 2 next month, was born with the hemispheres of his 
 brain fused. He is physically and mentally handicapped. 
 
 DeVivo is among a growing number of Americans spending up to $75,000 
 in the hope that clinics in developing countries have realized the 
 dream of regenerative medicine: using stem cells to fix the so-far 
 unfixable. 
 
 From Guatemala to Ukraine, dozens of stem-cell purveyors are selling 
 that dream over the Internet. They say they are helping patients whom 
 mainstream medicine cannot. And they purport to treat a stunning list 
 of illnesses, especially incurable conditions such as Parkinson's, 
 cerebral palsy and paralysis. 
 
 Their Web sites, many loaded with patient testimonials, offer little 
 or no scientific evidence to support their claims. 
 
 While no one knows exactly how big this new form of "medical tourism" 
 has grown, it is booming. One of the biggest stem-cell firms, Beike 
 Biotech -- whose slogan promises "tomorrow's treatments today" -- 
 says it has treated 3,000 Chinese and foreign patients at its 24 
 hospital clinics in China. 
 
 Mainstream researchers condemn stem-cell tourism as unethical and 
 dangerous, if not fraudulent. They urge patients to wait for rigorous 
 studies. 
 
 Wise Young, an internationally known spinal-cord-
 Rutgers University, declared: "Let's say these guys are making 
 $20,000 per patient. They're making hundreds of millions of dollars. 
 They can't take time to document it and publish it? This is the wrong 
 way to do it."
 
 For many patients, the proper way -- years of animal studies followed 
 by arduous human testing -- is too slow. They hope the experimental 
 cells hit the right targets, like magic bullets, even if humans are 
 shooting in the dark. 
 
 "I went to the Dominican Republic expecting a miracle," DeVivo, of 
 Valencia, Calif., wrote on her blog, prayfornathan.
 out of the clinic? Maybe he will say his first full, clear word. What 
 will it be?"
 
 Reprogramming cells A decade ago, when embryonic stem cells were 
 first isolated, the controversial cells were thought to be the only 
 ones that could give rise to all tissues in the body. 
 
 "Adult" stem cells, in contrast, were presumed to resupply only the 
 specialized tissue -- say, blood or fat -- that harbored them. 
 
 But now scientists can genetically reprogram specialized cells to be 
 as versatile as embryonic ones -- albeit only in the lab, with 
 methods that would be unsafe in humans. 
 
 Scientific advances, media hype and public confusion have fueled stem-
 cell tourism, critics say. 
 
 "There is a risk that patients who are desperate will misunderstand 
 the amount of progress," said Harvard University professor George 
 Daley, associate director of the Stem Cell Program at Children's 
 Hospital Boston. "It is fertile ground for exploitation.
 
 Most stem-cell purveyors claim to use blood stem cells. These cells --
  readily extracted from circulating blood, bone marrow, fetuses or 
 umbilical cords -- have been used since the 1960s to treat blood-
 system diseases such as leukemia and lymphoma. 
 
 There is no evidence that a shot of blood stem cells can magically 
 fix any problem in every organ system, experts say, but that's what 
 stem-cell tourists are led to believe. 
 
 William Rader, a psychiatrist in Malibu, Calif., who owns the 
 Dominican Republic clinic where Nathan was treated, says on his Web 
 site that the fetal blood stem cell "searches out, detects and then 
 attempts to repair any damage or deficiency discovered."
 
 Rader did not respond to requests for an interview. 
 
 Living with ambiguity Justin Lowery's case shows why mainstream 
 scientists want controlled studies -- and why patients won't wait. 
 
 Justin, of Carneys Point, N.J., was born blind, the result of 
 severely underdeveloped optic nerves. 
 
 In February, when he was 10 months old, the impact of his handicap 
 was obvious as physical therapist Karen Conner worked with him at 
 home. Justin couldn't roll onto his belly, crawl, or pull himself to 
 a standing position. 
 
 "What are you doing, big boy?" cooed his mother, Lora, as Conner 
 bounced Justin on a giant ball to strengthen his abdominal muscles. 
 
 The baby did not smile or laugh. He didn't reach for toys, even ones 
 with lights and sounds. He was easily startled. He recoiled at most 
 objects put in his hands. 
 
 Fast-forward to April, two days after Justin's first birthday -- 
 about a month after he and his parents flew home from Beike's clinic 
 in Hangzhou, China. 
 
 A reporter watched as Justin's eyes followed a lighted ball that 
 Conner moved in front of his face. He also pulled blinking balls out 
 of a plastic jar, crawled to get toys, knelt, and pulled himself up 
 using the sofa. 
 
 He often smiled. 
 
 Jonathan Salvin, Justin's ophthalmologist at Alfred I. du Pont 
 Hospital for Children in Wilmington, found no change in Justin's 
 optic nerves but called his ability to follow objects with his 
 eyes "a pretty significant improvement.
 
 Was it due to the Lowerys' $70,000 odyssey? 
 
 All Salvin could say for sure was that occasionally, vision gets 
 better as the brain matures early in life. 
 
 "I have seen improvement like this in kids who haven't had this 
 protocol," he said. 
 
 While the Lowerys can live with that ambiguity, researchers cannot. 
 
 "The unfortunate thing," said John Steeves, a spinal-cord-
 researcher at the University of British Columbia, "is that none of us 
 is learning anything that advances our scientific understanding.
 
 Immediate gains doubtful Many patients or families, including 
 Justin's, report neurological changes within 48 hours of receiving 
 stem cells. 
 
 Even stem-cell purveyors acknowledge that nerves cannot grow -- much 
 less regrow -- that fast. 
 
 "We believe these immediate results occur from the neural growth 
 factors used during the transplant process," says Beike's literature, 
 suggesting growth chemicals revive existing nerves. 
 
 Critics cite other factors: 
 
 Care that includes surgically opening an injured spinal cord may free 
 compressed nerves. 
 
 Believing is seeing, also known as the placebo effect. 
 
 No one wants to feel bilked, especially after fund-raisers and loans. 
 
 "The problem with folks who say, 'Things are a little better,' is 
 that they've just spent a lot of time and money," said Bruce Dobkin, 
 a neurologist and rehabilitation expert at the University of 
 California, Los Angeles. "And they think, 'Maybe I'll continue to get 
 better.' "
 
 Excruciating pain Six years ago, Tim Case, a workaholic New York real 
 estate developer, was talked into trying an all-terrain vehicle, just 
 for fun, by his 11-year-old son. 
 
 Case crashed into a tree and, in a heartbeat, ended his life as an 
 alpha male. 
 
 Although Case, 48, is a quadriplegic, he is not as disabled as actor 
 Christopher Reeve, who became a friend after the accident, was before 
 he died. Case doesn't need a ventilator, and has limited use of his 
 arms and hands. 
 
 Case, however, has a problem Reeve didn't have: unrelenting, 
 excruciating pain. 
 
 Case believes the pain -- which was intermittent and tolerable after 
 the accident -- was exacerbated by the cell transplant he received in 
 2003 from neurosurgeon Huang Hongyun in Beijing. 
 
 "I think it's just as important to report the negative as the 
 positive," Case said last month from a wheelchair in his Long Island 
 home. 
 
 Doctors used to dismiss such pain as imaginary. After all, how can a 
 limb that can't feel a pinprick feel pain? It is now clear that 
 broken nerves can send dysfunctional signals to the brain. 
 
 As Case can attest, these signals can defy pain drugs, including 
 opiates. 
 
 On CareCure, an online patient-support forum run by Rutgers' Young, 
 Case begged for advice. 
 
 "By 4:30 a.m., I am awake, screaming in pain, stiffness, burning, 
 very high spasm," he wrote in 2006. "Pain is killing, just 
 overwhelming.
 
 Early last year, he wrote: "There has to be an efficient way to end 
 my life. Some way to end the pain."
 
 Has it lessened since then? 
 
 "As I tell my wife," he said with a sad smile, "the only thing that 
 seems to change is my ability to tolerate more pain."
 
 Still, he insisted the treatment had been worth the risk. He would 
 try a newer version if he thought it would help. 
 
 "We're desperate," he said. "There's nothing else."
 
 Operations in China That, Huang and other purveyors say, is why cells 
 should be used even though it is not clear how they work. 
 
 "It is more reasonable and respectful to the patients," Huang e-
 mailed last month. "Any standard should consider patients as the key 
 factor."
 
 Huang worked at Rutgers for three years under Young's tutelage, 
 surgically implanting specialized cells into rats with spinal 
 injuries. While these cells are not stem cells, they are believed to 
 be key to the olfactory (smell) system's ability to replenish nerves -
 - something no other part of the nervous system can do. 
 
 In 2002, Huang returned to Beijing and began offering the rat 
 operation to humans. He said that on the standard neurological-
 impairment scale, patients had gained at least one grade of motor 
 function -- such as extending a formerly paralyzed wrist. Soon he 
 expanded the treatment to other problems, such as stroke and 
 amyotrophic lateral sclerosis. He also traveled widely, talking up 
 his methods to Western scientists. 
 
 Young, who was born in Hong Kong, has urged his former protege to 
 conduct controlled studies, called clinical trials -- as Young plans 
 to do late this year with doctors he has trained in China. 
 
 Huang "is delivering a treatment that he believes is effective," 
 Young said. "But I have strongly discouraged him. The Chinese 
 government dislikes it."
 
 Huang insisted that officials did not object to his procedure, which 
 he called safe. 
 
 Of 1,255 patients treated through last year, 76 had 
 complications, "including temporary headache, temporary modest fever, 
 incision infection, cerebrospinal fluid leakage, etc."
 
 For another view, UCLA's Dobkin and two colleagues found seven 
 patients who planned to get Huang's cell transplants for spinal-cord 
 injuries. 
 
 The Western doctors examined the patients before, after, and up to a 
 year later. 
 
 Their tiny study, published in 2006 in Neurorehabilitation and Neural 
 Repair, found that five of the seven patients had serious side 
 effects, including pneumonia, bleeding and meningitis. 
 
 None had significant improvements. 
 
 Going back for more And what of Marcela DeVivo, who hoped fetal stem 
 cells would work miracles for her then-18-month-
 
 Her blog has photos of that February trip to the Dominican Republic: 
 Here is Nathan, with his megawatt smile, gazing at Rader, the Malibu 
 psychiatrist. 
 
 Other photos show Nathan laughing as his mom dips him in the surf, or 
 being held by his father, Owen Andrew. 
 
 But there were no miracles. 
 
 DeVivo said the treatment still had been worth it. "I see little 
 changes, which in a child like Nathan are important," she wrote. "His 
 head and trunk are stronger. He is more alert. His tongue is moving 
 better."
 
 Back home, DeVivo again threw herself into obtaining anything that 
 might help Nathan, from physical and speech therapy to "transcranial 
 manipulation.
 
 By May, "tired and overwhelmed,
 Nathan."
 
 "Most importantly, Nathan doesn't need fixing. . . . Maybe he is here 
 to fix me."
 
 Still, she said recently, she can never stop seeking therapies to 
 help keep him healthy by preventing related problems, such as hip 
 dislocation and spinal curvature. 
 
 And those therapies include stem cells. 
 
 "We're going back in August for more stem cells," she said. "Going 
 back, it's less expensive -- $12,000."
 
 Contact staff writer Marie McCullough at 215-854-2720 or 
 mmccullough@
 
 ----- 
 
 To see more of The Philadelphia Inquirer, or to subscribe to the 
 newspaper, go to http://www.philly.
 
 Copyright (c) 2008, The Philadelphia Inquirer 
 
 Distributed by McClatchy-Tribune Information Services. 
 
 For reprints, email tmsreprints@
 7985 or 847-635-6550, send a fax to 847-635-6968, or write to The 
 Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 
 60025, USA.
 
 Source: The Philadelphia Inquirer
 http://www.redorbit
 experts/
 
 
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Special offer for Yahoo! Groups from Blockbuster! Get a free 1-month trial with no late fees or due dates.
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
1 comment:
It looks like tourism of cells had become a common thing. I am a doctor and I ususally have to travel to different countries taking chemicals from laboratories to other ones for examination. Last year I a dto go to Argentina. The good thing about my job is that you get good things as an apartment rental in Buenos Aires and some days off for the professional to meet the country. It is great, isn´t it?
I highly recommend BA, is one of the most developed cities in Latin America!
Julie
Post a Comment